Location History:
- Brooklyn, CT (US) (2010 - 2014)
- Harvard, MA (US) (2005 - 2018)
- Providence, RI (US) (2012 - 2019)
Company Filing History:
13 out of 470 
1 out of 1 Years Active: 2005-2025
Title: Innovator Spotlight: Justin R. Fallon
Introduction
Justin R. Fallon, an accomplished inventor based in Harvard, MA, has made significant contributions to the field of molecular biology and therapeutic development. With a total of 12 patents to his name, Fallon has focused primarily on innovations aimed at addressing critical health conditions associated with biglycan.
Latest Patents
Fallon's most recent patents concentrate on compositions and methodologies for treating, preventing, and diagnosing diseases related to abnormal levels or activities of biglycan. One notable invention, titled "Biglycan Variant Polypeptides and Methods of Use," proposes therapeutic approaches for conditions arising from unstable cytoplasmic membranes and dysfunctional synapses, which could potentially impact diseases such as Amyotrophic Lateral Sclerosis (ALS) and various muscular dystrophies.
Another patent, "Biglycan Mutants and Related Therapeutics and Methods of Use," presents innovative strategies for managing muscular dystrophies, including Duchenne's Muscular Dystrophy and Becker's Muscular Dystrophy. This research seeks to provide novel solutions for neuromuscular and neurological disorders linked to biglycan abnormalities.
Career Highlights
Justin R. Fallon has made his mark in the academic and corporate sectors through his work at renowned institutions such as Brown University and Tivorsan Pharmaceuticals, Inc. His experience in these respected organizations has contributed significantly to his research and innovation in the field.
Collaborations
Throughout his career, Fallon has collaborated with noteworthy professionals, including Beth A. McKechnie and Michael Rafii. These partnerships have furthered his research pursuits and enhanced the impact of his inventions on the scientific community.
Conclusion
Justin R. Fallon stands out as a prominent figure in the realm of innovative medical solutions. His groundbreaking work on biglycan-related therapies not only showcases his inventive spirit but also holds promise for improving the lives of individuals affected by challenging neuromuscular and neurological disorders. With a robust portfolio of patents, Fallon continues to pave the way for future advancements in medical science.